RSS   Newsletter   Contact   Advertise with us
Post Online Media

Achaogen appoints Liz Bhatt as CBO

Liz BhattAchaogen, a clinical-stage biopharmaceutical company, announced the addition of Liz Bhatt as chief business officer.

Ms. Bhatt brings to Achaogen more than 20 years of experience in corporate development and strategy in the biopharmaceutical industry.

Article continues below

READ MORE Achaogen promotes three executives

Most recently, Ms. Bhatt held the position of Vice President, Corporate Development at Gilead Sciences where she was responsible for executing licenses, acquisitions and collaborations across all of Gilead’s therapeutic areas.

While at Gilead, she also led long-term global commercial and strategic planning for Gilead’s antiviral and respiratory franchises.

Before Gilead, Ms. Bhatt held corporate development and strategy roles at Eli Lilly and Maxygen.

Ms. Bhatt earned a B.A. in Chemistry from Pomona College, an M.S. in Biomedical Sciences from the University of California.

What to read next


More inside POST

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy